- Home
- SGHT vs GRX Comparison
SGHT vs GRX Comparison
Compare SGHT & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- GRX
- Stock Information
- Founded
- SGHT 2011
- GRX 2007
- Country
- SGHT United States
- GRX United States
- Employees
- SGHT N/A
- GRX N/A
- Industry
- SGHT Medical Specialities
- GRX Finance/Investors Services
- Sector
- SGHT Health Care
- GRX Finance
- Exchange
- SGHT Nasdaq
- GRX Nasdaq
- Market Cap
- SGHT 140.1M
- GRX 156.7M
- IPO Year
- SGHT 2021
- GRX N/A
- Fundamental
- Price
- SGHT $2.25
- GRX $10.01
- Analyst Decision
- SGHT Buy
- GRX
- Analyst Count
- SGHT 7
- GRX 0
- Target Price
- SGHT $3.83
- GRX N/A
- AVG Volume (30 Days)
- SGHT 270.5K
- GRX 39.7K
- Earning Date
- SGHT 03-05-2025
- GRX 01-01-0001
- Dividend Yield
- SGHT N/A
- GRX 5.98%
- EPS Growth
- SGHT N/A
- GRX N/A
- EPS
- SGHT N/A
- GRX 0.26
- Revenue
- SGHT $79,866,000.00
- GRX N/A
- Revenue This Year
- SGHT $3.09
- GRX N/A
- Revenue Next Year
- SGHT $13.61
- GRX N/A
- P/E Ratio
- SGHT N/A
- GRX $38.50
- Revenue Growth
- SGHT N/A
- GRX N/A
- 52 Week Low
- SGHT $2.17
- GRX $7.73
- 52 Week High
- SGHT $8.45
- GRX $10.40
- Technical
- Relative Strength Index (RSI)
- SGHT 37.59
- GRX 48.55
- Support Level
- SGHT $2.64
- GRX $9.93
- Resistance Level
- SGHT $3.13
- GRX $10.02
- Average True Range (ATR)
- SGHT 0.22
- GRX 0.10
- MACD
- SGHT -0.05
- GRX 0.01
- Stochastic Oscillator
- SGHT 6.38
- GRX 50.00
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.